Stevens Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Stevens Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$891K	Buy	+14,694	New	+$857K	0.14%	94
2025 Q3	–	Sell	-9,705	Closed	-$449K	–	263
2025 Q2	$449K	Buy	+9,705	New	+$476K	0.12%	134
2025 Q1	–	Sell	-5,867	Closed	-$332K	–	253
2024 Q4	$332K	Sell	5,867 -22,625	-79%	-$1.26M	0.13%	206
2024 Q3	$1.47M	Buy	+28,492	New	+$1.34M	0.21%	60
2023 Q4	–	Sell	-16,098	Closed	-$934K	–	254
2023 Q3	$934K	Sell	16,098 -10,492	-39%	-$643K	0.27%	92
2023 Q2	$1.7M	Buy	26,590 +22,025	+482%	+$1.48M	0.35%	60
2023 Q1	$316K	Buy	+4,565	New	+$322K	0.08%	150
2021 Q4	–	Sell	-39,862	Closed	-$2.36M	–	240
2021 Q3	$2.36M	Buy	+39,862	New	+$2.63M	0.99%	26
2021 Q2	–	Sell	-18,694	Closed	-$1.18M	–	196
2021 Q1	$1.18M	Buy	+18,694	New	+$1.16M	0.65%	30
2020 Q1	–	Sell	-105,145	Closed	-$6.75M	–	50
2019 Q4	$6.75M	Buy	105,145 +21,410	+26%	+$1.23M	0.63%	38
2019 Q3	$4.25M	Sell	83,735 -104,070	-55%	-$4.89M	0.38%	74
2019 Q2	$8.52M	Sell	187,805 -39,149	-17%	-$1.82M	0.38%	68
2019 Q1	$10.8M	Buy	+226,954	New	+$11.3M	0.46%	55
2016 Q4	–	Sell	-97,875	Closed	-$5.28M	–	881
2016 Q3	$5.28M	Buy	+97,875	New	+$6.29M	0.22%	123
2016 Q2	–	Sell	-18,831	Closed	-$1.2M	–	911
2016 Q1	$1.2M	Buy	+18,831	New	+$1.19M	0.05%	377
2015 Q2	–	Sell	-12,914	Closed	-$833K	–	1029
2015 Q1	$833K	Buy	+12,914	New	+$808K	0.03%	455
2014 Q3	–	Sell	-4,506	Closed	-$219K	–	1007
2014 Q2	$219K	Sell	4,506 -79,275	-95%	-$3.91M	0.01%	905
2014 Q1	$4.35M	Buy	+83,781	New	+$4.46M	0.12%	210
2013 Q3	–	Sell	-9,588	Closed	-$428K	–	1030
2013 Q2	$428K	Buy	+9,588	New	+$416K	0.01%	616

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stevens Capital Management's BMY Position: Q1 2026 in Review

Stevens Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 14,694 shares worth $891K. The stake represents 0.14% of the portfolio and ranks #94 among its holdings. This is a return to the name: Stevens Capital Management previously reported a position in BMY as recently as Q2 2025.

Stevens Capital Management first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $10.8M in Q1 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Stevens Capital Management held 14,694 shares of Bristol-Myers Squibb worth $891K as of Q1 2026.
Bristol-Myers Squibb was a new Stevens Capital Management position in Q1 2026.
Bristol-Myers Squibb made up 0.14% of Stevens Capital Management's portfolio in Q1 2026, its #94 holding.
Stevens Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
Stevens Capital Management's Bristol-Myers Squibb position peaked at $10.8M in Q1 2019.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Stevens Capital Management's 13F filing for Q1 2026, filed 11 May 2026.